Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Mirabegron compared with Solifenacin in adults with overactive bladder who were unsatisfied with prior the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Urologic Diseases, Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED | Results posted: 2016-08-30